Starting today, Rêve Health members can add GRAIL’s Galleri® test—a first-of-its-kind, clinically validated blood test that detects a shared cancer signal across more than 50 types of cancer—to their personalized wellness journey.
As over 600,000 Americans are expected to lose their lives to cancer in 2025, early detection remains one of the most powerful ways to shift the outcome.
The Galleri® test identifies a unique cancer signal in the bloodstream, often before symptoms appear, enabling proactive intervention for cancers such as pancreatic, ovarian, and esophageal—many of which currently lack routine screening tools.
At Rêve Health, we believe prevention is only part of the equation—true health also requires meaning, balance, and insight.
By offering the Galleri test alongside our comprehensive lab panel, Eastern diagnostic principles, and guidance on life purpose, we are empowering our members to take control of their health from every angle: physical, energetic, and emotional.
